ANAB (AnaptysBio Inc) Sof foyda

ANAB (AnaptysBio) - kompaniyaning tovar belgisi

AnaptysBio, Inc. (ANAB) marjalarni himoya qilish uchun bir nechta pudratchilardan foydalangan holda, sinovlar uchun biomateriallar ta'minotini optimallashtirmoqda. Ushbu grafikdagi narx ko'rsatkichi foyda dinamikasini aks ettiradi, u hozirda 0.19 darajasida turibdi, daromadlar esa antitanachalar ishlab chiqish uchun grantlar va litsenziyalarga tayanadi. Huquqlarni erta bosqichlarda sanoat gigantlariga o'tkazish strategiyasi kompaniyaga narxlar urushidan qochish imkonini beradi va etapma-etap to'lovlarning barqaror oqimini ta'minlaydi.

ANAB (AnaptysBio, Inc.) Sof foyda tarixi 04.07.2022dan 29.10.2026gacha

AnaptysBio (ANAB) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari AnaptysBio Inc.|ANAB - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor kapitallashuvi AnaptysBio Inc.|ANAB - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Aksiyaning buxgalteriya qiymati AnaptysBio|ANAB - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi anaptysbio.com|ANAB - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati AnaptysBio, Inc.|ANAB - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati AnaptysBio Inc|ANAB - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar AnaptysBio Inc.|ANAB - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi AnaptysBio|Shoshilinch likvidlik anaptysbio.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
ANAB - Sof foyda
Kompaniyaning jamlanma tahlili:AnaptysBio, Inc.
AnaptysBio Corp asosiy tovari

Foyda barcha operatsion va nooperatsion xarajatlar chegirib tashlanganidan keyingi sof moliyaviy natijani aks ettiradi. Ushbu ko'rsatkich kapitalni boshqarish samaradorligini va biznesning qiymat yaratish qobiliyatini o'lchaydi. Kompaniyaning foyda tarixini tahlil qilish orqali investor pul oqimlarining barqarorligini baholashi mumkin. AnaptysBio, Inc. (ANAB) uchun ushbu metrika bevosita antitelolarni litsenziyalashdan olinadigan royalti to'lovlariga bog'liq. Ishlab chiqishni diversifikatsiya qilish ushbu grafikda ko'rsatilgan daromadlar tebranishlarini yumshatish imkonini beradi.

Asosiy raqobatchilar

Sof daromad argenx BVBA|BNTX (BioNTech SE) - Sof foyda|Sof foyda Abivax Pharma|Sof daromad ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Yakuniy foyda|Sof foyda IMVT (Immunovant Corp)|Sof moliyaviy natija Kiniksa Corp (KNSA)|GRFS - Kompaniyaning sof foydasi|adaptivebiotech.com (ADPT) - Sof daromad|Celldex Therapeutics, Inc. (CLDX) - Kompaniyaning sof foydasi|Sof daromad Aurinia Pharmaceuticals Inc|Sof daromad BCRX|Sof foyda Vera Corp|Kompaniyaning sof foydasi Dianthus Therapeutics (DNTH)|pharvaris.com - Kompaniya foydasi|Sof foyda ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Kompaniyaning sof daromadi|Intrexon - Sof foyda|PHAR - Sof foyda|Nektar Therapeutics (NKTR) - Kompaniyaning sof foydasi|Kompaniya foydasi UPB|ZBIO (Zenas Biopharma) - Sof foyda|Sof foyda Immunome Inc|Kompaniyaning sof foydasi Gossamer Corp (GOSS)|KALV: Soliqdan keyingi foyda|Septerna Inc - Sof daromad|Soliqlar to‘langandan keyingi foyda PVLA (pieris.com)|SVRA: Sof daromad|Kompaniyaning sof daromadi Rigel Pharma|Astria Pharma (ATXS) - Kompaniyaning sof foydasi|ENGN - Sof moliyaviy natija|RAPT (RAPT Therapeutics, Inc.) - Sof foyda|Kompaniyaning sof foydasi JBIO|Sof foyda ACRS|Sof moliyaviy natija Kyverna Therapeutics Inc.|Kompaniyaning sof foydasi Tiziana Life Sciences PLC TLSA|Cabaletta Bio Inc (CABA) - Kompaniyaning sof daromadi|VTYX: Sof daromad|Yakuniy foyda THTX (theratech.com)|AVTX: Sof foyda|ELDN - Sof moliyaviy natija|Kompaniyaning sof foydasi Agenus Inc|Kompaniya foydasi CLYM (Climb Bio, Inc)|Sof foyda ZURA|Sof daromad atyrpharma.com ATYR|Adagene Inc. - Sof daromad|Sof moliyaviy natija ImageneBio (IMA)|Shattuck Therapeutics - Sof foyda|EQ - Sof foyda|connectbiopharm.com (CNTB) - Kompaniyaning sof foydasi|Kompaniya foydasi IMUX|ATRA (Atara Biotherapeutics, Inc.) - Sof foyda|Sof foyda InflaRx GmbH|Sof foyda XFOR|Kompaniyaning sof foydasi ACET (adicetbio.com)|Kompaniyaning sof foydasi Celularity CELU|INMB (inmunebio.com) - Soliqdan keyingi foyda|Barinthus Biotherapeutics plc - Sof foyda|Yakuniy foyda KZR (Kezar Life Sciences Inc.)|SABS: Sof foyda|Akari Therapeutics, Plc (AKTX) - Sof foyda|Kompaniyaning sof foydasi Enlivex Therapeutics Ltd|QTTB: Yakuniy foyda|Kompaniyaning sof foydasi GeoVax (GOVX)|Sof daromad Edesa Biotech Inc EDSA|Sof foyda IBIO (iBio Corp)|Sof foyda Carisma Therapeutics Inc CARM|XTLB: Sof daromad|Yakuniy foyda BOLT (Bolt Biotherapeutics)|HCWB: Sof foyda|APVO - Sof moliyaviy natija|Kompaniyaning sof foydasi AIM ImmunoTech|Sof daromad Aditxt Corp (ADTX)|Kompaniyaning sof foydasi GRI Bio, Inc. (GRI)|Sof daromad xortx.com XRTX|Vyome Holdings - Sof daromad|Sof foyda Revelation Biosciences Inc REVB|INDP - Kompaniyaning sof foydasi|SCNI (BiondVax Pharmaceuticals) - Kompaniya foydasi|CALI: Sof foyda|Kompaniyaning sof daromadi Affimed N.V. (AFMD)|ALLK (Allakos Inc) - Sof foyda|Sof foyda HOOKIPA|Kompaniyaning sof foydasi IGM Biosciences, Inc. (IGMS)|iTeos Pharma - Kompaniya foydasi|Sof foyda OCEA (Ocean Biomedical, Inc.)|Sof foyda tcbiopharm.com TCBP|THRD - Kompaniyaning sof foydasi